Cellectar Biosciences Inc. (NASDAQ: CLRB) Stock Information | RedChip

Cellectar Biosciences Inc. (NASDAQ: CLRB)


$0.2483
+0.0133 ( +3.46% ) 778.7K

Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. Its PDC therapeutic, iopofosine is a small-molecule PDC designed to provide targeted delivery of iodine-131 directly to cancer cells, while limiting exposure to healthy cells.

Market Data


Open


$0.2483

Previous close


$0.2350

Volume


778.7K

Market cap


$9.70M

Day range


$0.2310 - $0.2490

52 week range


$0.2240 - $4.4500

SEC Filings


Form Type Description Pages Date
nt Quarterly Reports 1 Aug 14, 2024
8-k 8K-related 14 Aug 13, 2024
8-k 8K-related 13 Aug 09, 2024
8-k 8K-related 15 Jul 23, 2024
8-k 8K-related 19 Jul 22, 2024
8-k 8K-related 16 Jul 11, 2024
8-k 8K-related 13 Jun 25, 2024
4 Insider transactions 1 Jun 18, 2024
4 Insider transactions 1 Jun 18, 2024
4 Insider transactions 1 Jun 18, 2024

Latest News